
HYPMY
Healthcare · Drug Manufacturers - Specialty & Generic · $2.77B market cap
$4.02+0.04 (+1.0%)Nov 13, 10:17 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2025 | Time not confirmed | — | 0.72 | — |
| Aug 6, 2025 | Time not confirmed | — | 0.68 | — |
| Apr 24, 2025 | After the close | — | -0.04 | — |
| Mar 11, 2025 | After the close | — | 0.02 | — |
| Nov 6, 2024 | After the close | — | 0.11 | — |
| Jul 25, 2024 | After the close | — | 0.15 | — |
| Apr 26, 2024 | After the close | — | 0.12 | — |
| Mar 14, 2024 | Before the open | — | 0.10 | — |
| Sep 30, 2021 | Time not confirmed | — | 0.14 | — |
| Jun 30, 2021 | Time not confirmed | — | 0.15 | — |
| Mar 31, 2021 | Time not confirmed | — | 0.09 | — |
| Dec 31, 2020 | Time not confirmed | — | 0.10 | — |
| Sep 30, 2020 | Time not confirmed | — | 0.10 | — |
| Jun 30, 2020 |
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR,…
| Time not confirmed |
| — |
| 0.11 |
| — |
| Mar 31, 2020 | Time not confirmed | — | 0.07 | — |
| Dec 31, 2019 | Time not confirmed | — | 0.10 | — |
| Sep 30, 2019 | Time not confirmed | — | 0.10 | — |
| Jun 30, 2019 | Time not confirmed | — | 0.14 | — |
| Mar 31, 2019 | Time not confirmed | — | 0.13 | — |
| Dec 31, 2018 | Time not confirmed | — | 0.13 | — |
| Sep 30, 2018 | Time not confirmed | — | 0.10 | — |
| Jun 30, 2018 | Time not confirmed | — | 0.11 | — |
| Mar 31, 2018 | Time not confirmed | — | 0.14 | — |